BridgeMD
New treatment option for Isolated Intrabony Periodontal Defects in Patients With Periodontitis
Official title Clinical and Radiographic Evaluation of Using the Entire Papilla Preservation Technique With and Without Autogenous Bone Graft and Injectable Platelet Rich Fibrin in Treatment of Periodontal Intraosseous Defects
ClinicalTrials.gov ID: NCT06347263
What this study is testing
- What it's testing
- The goal of this Clinical trial is to evaluate the clinical and radiographic outcomes of using entire papilla preservation technique with and without autogenous bone and injectable platelet rich fibrin in treatment of isolated Intrabony defects in patients with stage III periodontitis.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50. Healthy volunteers may be eligible.
You may be able to join if
- Patients with healthy systemic condition.
- Adult patients (18 years old and older).
- Patients with stage lll periodontitis, having one isolated intrabony defect with probing depth \>6mm, clinical attachment level\> 6mm and at least 4...
- Patients with full mouth plaque score\<20%.
- Patients with full mouth bleeding score\<20%.
You likely can't join if
- Ongoing drug therapy that might have an impact on the clinical signs and symptoms of periodontitis.
- One wall intrabony defect.
- Defects that involve the buccal and lingual sites.
- Smokers ˃ 10 cigarettes / day.
- Pregnant and lactating females.
See the full eligibility criteria
- Patients with healthy systemic condition.
- Adult patients (18 years old and older).
- Patients with stage lll periodontitis, having one isolated intrabony defect with probing depth \>6mm, clinical attachment level\> 6mm and at least 4 mm intrabony component involving predominantly the interproximal area...
- Patients with full mouth plaque score\<20%.
- Patients with full mouth bleeding score\<20%.
- Compliance with good oral hygiene.
- Patients accept 6-months follow-up period (cooperative patients).
- Patients provide an informed consent.
- Ongoing drug therapy that might have an impact on the clinical signs and symptoms of periodontitis.
- One wall intrabony defect.
- Defects that involve the buccal and lingual sites.
- Smokers ˃ 10 cigarettes / day.
- Pregnant and lactating females.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.